Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
Therapie|May 2, 2020
Daily practices regarding safety monitoring of low-dose methotrexate and comparison to guidelines: A population-based cohort studyCanelle Mazaud, Laurence FardetClinical Rheumatology|May 10, 2015
Systemic glucocorticoid therapy: risk factors for reported adverse events and beliefs about the drug. A cross-sectional online survey of 820 patientsClément Morin, Laurence FardetDrugs|September 11, 2014
Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse eventsLaurence Fardet, Bruno FèvePresse Medicale (Paris, France : 1983)|October 25, 2002
[Non-selective and selective non-steroidal anti-inflammatory drugs, administration in pregnancy and breast feeding]Laurence Fardet, Jacky Nizard, Thierry GénéreauPlos Medicine|May 25, 2016
Common Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort StudyLaurence Fardet, Irene Petersen, Irwin NazarethBMJ (Clinical Research Ed.)|August 1, 2012
Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing's syndrome: cohort studyLaurence Fardet, Irene Petersen, Irwin NazarethThe American Journal of Psychiatry|July 6, 2012
Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary careLaurence Fardet, Irene Petersen, Irwin NazarethRheumatology (Oxford, England)|September 1, 2020
Long-term systemic glucocorticoid therapy and weight gain: a population-based cohort studyLaurence Fardet, Irwin Nazareth, Irene PetersenRheumatology (Oxford, England)|March 12, 2011
Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 yearsLaurence Fardet, Irene Petersen, Irwin NazarethMedicine|April 18, 2015
Monitoring of patients on long-term glucocorticoid therapy: a population-based cohort studyLaurence Fardet, Irene Petersen, Irwin NazarethPageof 6